Atorvastatin does not alter interferon beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis

Archives of Neurology

Volumn 65, Issue 5, 2008, Pages 672-674

  Sellner, Johann ^a   Greeve, Isabell ^b   Leib, Stephen L ^b   Mattle, Heinrich P ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERFERON BETA SERINE; PREDNISONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG MECHANISM; HUMAN; IMMUNOMODULATION; LETTER; MONOTHERAPY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PYRROLES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TREATMENT OUTCOME;

EID: 43549116619     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.5.672     Document Type: Letter

References (7)